Prediction of high-grade cervical intraepithelial neoplasia in cytologically normal women by human papillomavirus testing View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2000-11-14

AUTHORS

F Carozzi, G Ronco, M Confortini, D Noferini, C Maddau, S Ciatto, N Segnan

ABSTRACT

Human papillomavirus (HPV) testing has been suggested for primary screening of cervical cancer. Prediction of future high-grade cervical lesions is crucial for effectiveness and cost. We performed a case control study in a retrospective cohort of women with at least two cervical smears, all but the last one being negative, from the organized cervical screening programme in Florence, Italy. We searched for high-risk HPV in all previous, archival, smears from cases (new histologically confirmed cervical intraepithelial neoplasia (CIN) grade II or worse) and in one previous smear from each control (last smear cytologically normal, matched by age and interval (latency) from last smear). We applied polymerase chain reaction (PCR), and the b-globin gene was used as a DNA preservation marker. High-risk HPV was identified in 71/92 (77.17%) previous smears from 79 cases and 17/332 controls (5.12%). The odds ratio (OR) was 63.76 (95% CI 30.57–132.96). Among cases the proportion of HPV-positive smears declined slightly with increasing latency. Among cases, HPV was found in 81.24% (95% CI 69.93–88.96%) of smears with latency < 4 years and in 67.80% (95% CI 47.72–82.93%) of those taken at longer intervals, up to 6 years. These findings suggest that testing for high-risk HPV allows predicting 80% of CINII/III 3 years before the cytological diagnosis and two thirds 6 years before. They also suggest that testing women negative for high-risk HPV at longer interval and strictly following-up women who are HPV positive could be an effective strategy for cervical cancer screening. © 2000 Cancer Research Campaign http://www.bjcancer.com More... »

PAGES

1462-1467

Identifiers

URI

http://scigraph.springernature.com/pub.10.1054/bjoc.2000.1491

DOI

http://dx.doi.org/10.1054/bjoc.2000.1491

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1007954422

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/11076654


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1117", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Public Health and Health Services", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Case-Control Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cervical Intraepithelial Neoplasia", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cervix Uteri", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "DNA, Viral", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Globins", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Papillomaviridae", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Papillomavirus Infections", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Predictive Value of Tests", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Retrospective Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Time Factors", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Tumor Virus Infections", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Uterine Cervical Neoplasms", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Cytology Unit, Centre for Cancer Study and Prevention (CSPO), Firenze, Italy", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Cytology Unit, Centre for Cancer Study and Prevention (CSPO), Firenze, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Carozzi", 
        "givenName": "F", 
        "id": "sg:person.0673306461.39", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0673306461.39"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Cancer Epidemiology Unit, ASL TO1, Centre for Cancer Epidemiology and Prevention (CPO), Torino, Italy", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Cancer Epidemiology Unit, ASL TO1, Centre for Cancer Epidemiology and Prevention (CPO), Torino, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ronco", 
        "givenName": "G", 
        "id": "sg:person.01206540103.18", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01206540103.18"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Cytology Unit, Centre for Cancer Study and Prevention (CSPO), Firenze, Italy", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Cytology Unit, Centre for Cancer Study and Prevention (CSPO), Firenze, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Confortini", 
        "givenName": "M", 
        "id": "sg:person.0667445361.38", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0667445361.38"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Cytology Unit, Centre for Cancer Study and Prevention (CSPO), Firenze, Italy", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Cytology Unit, Centre for Cancer Study and Prevention (CSPO), Firenze, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Noferini", 
        "givenName": "D", 
        "id": "sg:person.01303355111.07", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01303355111.07"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Cytology Unit, Centre for Cancer Study and Prevention (CSPO), Firenze, Italy", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Cytology Unit, Centre for Cancer Study and Prevention (CSPO), Firenze, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Maddau", 
        "givenName": "C", 
        "id": "sg:person.01116545420.18", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01116545420.18"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Diagnostic Medical Imaging, Centre for Cancer Study and Prevention (CSPO), Florence, Italy", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Department of Diagnostic Medical Imaging, Centre for Cancer Study and Prevention (CSPO), Florence, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ciatto", 
        "givenName": "S", 
        "id": "sg:person.01174274056.26", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01174274056.26"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Cancer Epidemiology Unit, ASL TO1, Centre for Cancer Epidemiology and Prevention (CPO), Torino, Italy", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Cancer Epidemiology Unit, ASL TO1, Centre for Cancer Epidemiology and Prevention (CPO), Torino, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Segnan", 
        "givenName": "N", 
        "id": "sg:person.0743542266.47", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0743542266.47"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1038/sj.bjc.6690523", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1041726872", 
          "https://doi.org/10.1038/sj.bjc.6690523"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/bjc.1989.236", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1022777795", 
          "https://doi.org/10.1038/bjc.1989.236"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/bjc.1997.440", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1010481383", 
          "https://doi.org/10.1038/bjc.1997.440"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/bjc.1991.350", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1042218657", 
          "https://doi.org/10.1038/bjc.1991.350"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf00051652", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1032711152", 
          "https://doi.org/10.1007/bf00051652"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/bjc.1995.347", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1010276001", 
          "https://doi.org/10.1038/bjc.1995.347"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.bjc.6690730", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1011080887", 
          "https://doi.org/10.1038/sj.bjc.6690730"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2000-11-14", 
    "datePublishedReg": "2000-11-14", 
    "description": "Human papillomavirus (HPV) testing has been suggested for primary screening of cervical cancer. Prediction of future high-grade cervical lesions is crucial for effectiveness and cost. We performed a case control study in a retrospective cohort of women with at least two cervical smears, all but the last one being negative, from the organized cervical screening programme in Florence, Italy. We searched for high-risk HPV in all previous, archival, smears from cases (new histologically confirmed cervical intraepithelial neoplasia (CIN) grade II or worse) and in one previous smear from each control (last smear cytologically normal, matched by age and interval (latency) from last smear). We applied polymerase chain reaction (PCR), and the b-globin gene was used as a DNA preservation marker. High-risk HPV was identified in 71/92 (77.17%) previous smears from 79 cases and 17/332 controls (5.12%). The odds ratio (OR) was 63.76 (95% CI 30.57\u2013132.96). Among cases the proportion of HPV-positive smears declined slightly with increasing latency. Among cases, HPV was found in 81.24% (95% CI 69.93\u201388.96%) of smears with latency < 4 years and in 67.80% (95% CI 47.72\u201382.93%) of those taken at longer intervals, up to 6 years. These findings suggest that testing for high-risk HPV allows predicting 80% of CINII/III 3 years before the cytological diagnosis and two thirds 6 years before. They also suggest that testing women negative for high-risk HPV at longer interval and strictly following-up women who are HPV positive could be an effective strategy for cervical cancer screening. \u00a9 2000 Cancer Research Campaign http://www.bjcancer.com", 
    "genre": "article", 
    "id": "sg:pub.10.1054/bjoc.2000.1491", 
    "inLanguage": "en", 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1017082", 
        "issn": [
          "0007-0920", 
          "1532-1827"
        ], 
        "name": "British Journal of Cancer", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "11", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "83"
      }
    ], 
    "keywords": [
      "high-risk HPV", 
      "previous smears", 
      "polymerase chain reaction", 
      "odds ratio", 
      "high-grade cervical lesions", 
      "human papillomavirus testing", 
      "cervical screening programme", 
      "cervical cancer screening", 
      "case-control study", 
      "HPV-positive smears", 
      "longer intervals", 
      "retrospective cohort", 
      "cervical cancer", 
      "cervical lesions", 
      "cancer screening", 
      "cervical smears", 
      "screening program", 
      "HPV", 
      "cytological diagnosis", 
      "control study", 
      "smears", 
      "chain reaction", 
      "primary screening", 
      "women", 
      "years", 
      "screening", 
      "effective strategy", 
      "lesions", 
      "cohort", 
      "cancer", 
      "cases", 
      "diagnosis", 
      "interval", 
      "latency", 
      "testing", 
      "control", 
      "markers", 
      "proportion", 
      "findings", 
      "study", 
      "genes", 
      "program", 
      "b-globin gene", 
      "strategies", 
      "effectiveness", 
      "ratio", 
      "Italy", 
      "last one", 
      "reaction", 
      "Florence", 
      "cost", 
      "one", 
      "prediction", 
      "archival"
    ], 
    "name": "Prediction of high-grade cervical intraepithelial neoplasia in cytologically normal women by human papillomavirus testing", 
    "pagination": "1462-1467", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1007954422"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1054/bjoc.2000.1491"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "11076654"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1054/bjoc.2000.1491", 
      "https://app.dimensions.ai/details/publication/pub.1007954422"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-05-20T07:21", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220519/entities/gbq_results/article/article_330.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1054/bjoc.2000.1491"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1054/bjoc.2000.1491'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1054/bjoc.2000.1491'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1054/bjoc.2000.1491'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1054/bjoc.2000.1491'


 

This table displays all metadata directly associated to this object as RDF triples.

254 TRIPLES      22 PREDICATES      103 URIs      88 LITERALS      23 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1054/bjoc.2000.1491 schema:about N131c75066ebb401a861244a221a6db14
2 N22abeceaa9fd4d7496ef91afe0ce2b8e
3 N416e42b54b944f5ab874e50cb4561c74
4 N45c793e004d3497694793c569a727f11
5 N4c7ebe5dbd02474cacd8812f51af96cd
6 N4f994ac379654e79a5d1a18ac52b386a
7 N5573a9b1a25b44ceb72319c3a9f360a1
8 N579c4a64473b4477b08d0043691aef40
9 N6f58d2f161fa40c89edc38cdb46f0b58
10 N8ac361b4f998428887c3845defd6ec51
11 Na120cf60daa54ee18067476fdf041b54
12 Na2e6861147224d5a8c2afbe68aaa7029
13 Naeeb9f81d10446c3a27e2e103335ae75
14 Ncd414df3cd664d50aa74c5162ea7c330
15 Nefd48a9d319a4436804fe7b25cee4b0f
16 Nf6d82f7012d44bba8794b9e771f40127
17 anzsrc-for:11
18 anzsrc-for:1117
19 schema:author Nce34bc0f80944fc4a26a5e7251833845
20 schema:citation sg:pub.10.1007/bf00051652
21 sg:pub.10.1038/bjc.1989.236
22 sg:pub.10.1038/bjc.1991.350
23 sg:pub.10.1038/bjc.1995.347
24 sg:pub.10.1038/bjc.1997.440
25 sg:pub.10.1038/sj.bjc.6690523
26 sg:pub.10.1038/sj.bjc.6690730
27 schema:datePublished 2000-11-14
28 schema:datePublishedReg 2000-11-14
29 schema:description Human papillomavirus (HPV) testing has been suggested for primary screening of cervical cancer. Prediction of future high-grade cervical lesions is crucial for effectiveness and cost. We performed a case control study in a retrospective cohort of women with at least two cervical smears, all but the last one being negative, from the organized cervical screening programme in Florence, Italy. We searched for high-risk HPV in all previous, archival, smears from cases (new histologically confirmed cervical intraepithelial neoplasia (CIN) grade II or worse) and in one previous smear from each control (last smear cytologically normal, matched by age and interval (latency) from last smear). We applied polymerase chain reaction (PCR), and the b-globin gene was used as a DNA preservation marker. High-risk HPV was identified in 71/92 (77.17%) previous smears from 79 cases and 17/332 controls (5.12%). The odds ratio (OR) was 63.76 (95% CI 30.57–132.96). Among cases the proportion of HPV-positive smears declined slightly with increasing latency. Among cases, HPV was found in 81.24% (95% CI 69.93–88.96%) of smears with latency < 4 years and in 67.80% (95% CI 47.72–82.93%) of those taken at longer intervals, up to 6 years. These findings suggest that testing for high-risk HPV allows predicting 80% of CINII/III 3 years before the cytological diagnosis and two thirds 6 years before. They also suggest that testing women negative for high-risk HPV at longer interval and strictly following-up women who are HPV positive could be an effective strategy for cervical cancer screening. © 2000 Cancer Research Campaign http://www.bjcancer.com
30 schema:genre article
31 schema:inLanguage en
32 schema:isAccessibleForFree true
33 schema:isPartOf N32b3cd3e32c042078dc635f14dbcd293
34 Nc4a65eb0f9c34b36904f25cb2a5f1b24
35 sg:journal.1017082
36 schema:keywords Florence
37 HPV
38 HPV-positive smears
39 Italy
40 archival
41 b-globin gene
42 cancer
43 cancer screening
44 case-control study
45 cases
46 cervical cancer
47 cervical cancer screening
48 cervical lesions
49 cervical screening programme
50 cervical smears
51 chain reaction
52 cohort
53 control
54 control study
55 cost
56 cytological diagnosis
57 diagnosis
58 effective strategy
59 effectiveness
60 findings
61 genes
62 high-grade cervical lesions
63 high-risk HPV
64 human papillomavirus testing
65 interval
66 last one
67 latency
68 lesions
69 longer intervals
70 markers
71 odds ratio
72 one
73 polymerase chain reaction
74 prediction
75 previous smears
76 primary screening
77 program
78 proportion
79 ratio
80 reaction
81 retrospective cohort
82 screening
83 screening program
84 smears
85 strategies
86 study
87 testing
88 women
89 years
90 schema:name Prediction of high-grade cervical intraepithelial neoplasia in cytologically normal women by human papillomavirus testing
91 schema:pagination 1462-1467
92 schema:productId N3b6ab26a725047349d803229ba34f8bd
93 Nb948d8e6b3e9470f858f9301291bae1b
94 Nc63ff54f7a0345858de4cf8587bb60b3
95 schema:sameAs https://app.dimensions.ai/details/publication/pub.1007954422
96 https://doi.org/10.1054/bjoc.2000.1491
97 schema:sdDatePublished 2022-05-20T07:21
98 schema:sdLicense https://scigraph.springernature.com/explorer/license/
99 schema:sdPublisher N243204a91b03426b89366d3b42f708db
100 schema:url https://doi.org/10.1054/bjoc.2000.1491
101 sgo:license sg:explorer/license/
102 sgo:sdDataset articles
103 rdf:type schema:ScholarlyArticle
104 N0fd77b02c5e64d71b3867cffb9cab4e8 rdf:first sg:person.01206540103.18
105 rdf:rest N7d09eee85be244e08c0f84a93196b347
106 N131c75066ebb401a861244a221a6db14 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
107 schema:name Case-Control Studies
108 rdf:type schema:DefinedTerm
109 N22abeceaa9fd4d7496ef91afe0ce2b8e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
110 schema:name Tumor Virus Infections
111 rdf:type schema:DefinedTerm
112 N243204a91b03426b89366d3b42f708db schema:name Springer Nature - SN SciGraph project
113 rdf:type schema:Organization
114 N32b3cd3e32c042078dc635f14dbcd293 schema:volumeNumber 83
115 rdf:type schema:PublicationVolume
116 N3b6ab26a725047349d803229ba34f8bd schema:name doi
117 schema:value 10.1054/bjoc.2000.1491
118 rdf:type schema:PropertyValue
119 N416e42b54b944f5ab874e50cb4561c74 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
120 schema:name Uterine Cervical Neoplasms
121 rdf:type schema:DefinedTerm
122 N45c793e004d3497694793c569a727f11 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
123 schema:name Cervical Intraepithelial Neoplasia
124 rdf:type schema:DefinedTerm
125 N4c7ebe5dbd02474cacd8812f51af96cd schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
126 schema:name Middle Aged
127 rdf:type schema:DefinedTerm
128 N4f994ac379654e79a5d1a18ac52b386a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
129 schema:name Retrospective Studies
130 rdf:type schema:DefinedTerm
131 N4f9fdc4e7e954fd19ec26b71fb2047f6 rdf:first sg:person.01303355111.07
132 rdf:rest Nf6618c86bf1841f7a4c55bb4ce162274
133 N5573a9b1a25b44ceb72319c3a9f360a1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
134 schema:name Cervix Uteri
135 rdf:type schema:DefinedTerm
136 N579c4a64473b4477b08d0043691aef40 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
137 schema:name Papillomavirus Infections
138 rdf:type schema:DefinedTerm
139 N6f58d2f161fa40c89edc38cdb46f0b58 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
140 schema:name Predictive Value of Tests
141 rdf:type schema:DefinedTerm
142 N7d09eee85be244e08c0f84a93196b347 rdf:first sg:person.0667445361.38
143 rdf:rest N4f9fdc4e7e954fd19ec26b71fb2047f6
144 N8ac361b4f998428887c3845defd6ec51 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
145 schema:name Globins
146 rdf:type schema:DefinedTerm
147 Na120cf60daa54ee18067476fdf041b54 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
148 schema:name Female
149 rdf:type schema:DefinedTerm
150 Na2e6861147224d5a8c2afbe68aaa7029 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
151 schema:name DNA, Viral
152 rdf:type schema:DefinedTerm
153 Naeeb9f81d10446c3a27e2e103335ae75 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
154 schema:name Humans
155 rdf:type schema:DefinedTerm
156 Nb948d8e6b3e9470f858f9301291bae1b schema:name pubmed_id
157 schema:value 11076654
158 rdf:type schema:PropertyValue
159 Nbcf4ddbc31e04dc8ae12a5478dd33eda rdf:first sg:person.0743542266.47
160 rdf:rest rdf:nil
161 Nc4a65eb0f9c34b36904f25cb2a5f1b24 schema:issueNumber 11
162 rdf:type schema:PublicationIssue
163 Nc63ff54f7a0345858de4cf8587bb60b3 schema:name dimensions_id
164 schema:value pub.1007954422
165 rdf:type schema:PropertyValue
166 Ncd414df3cd664d50aa74c5162ea7c330 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
167 schema:name Time Factors
168 rdf:type schema:DefinedTerm
169 Nce34bc0f80944fc4a26a5e7251833845 rdf:first sg:person.0673306461.39
170 rdf:rest N0fd77b02c5e64d71b3867cffb9cab4e8
171 Nefd48a9d319a4436804fe7b25cee4b0f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
172 schema:name Adult
173 rdf:type schema:DefinedTerm
174 Nf6618c86bf1841f7a4c55bb4ce162274 rdf:first sg:person.01116545420.18
175 rdf:rest Nfd442a16782642d7b1a339266c1f7139
176 Nf6d82f7012d44bba8794b9e771f40127 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
177 schema:name Papillomaviridae
178 rdf:type schema:DefinedTerm
179 Nfd442a16782642d7b1a339266c1f7139 rdf:first sg:person.01174274056.26
180 rdf:rest Nbcf4ddbc31e04dc8ae12a5478dd33eda
181 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
182 schema:name Medical and Health Sciences
183 rdf:type schema:DefinedTerm
184 anzsrc-for:1117 schema:inDefinedTermSet anzsrc-for:
185 schema:name Public Health and Health Services
186 rdf:type schema:DefinedTerm
187 sg:journal.1017082 schema:issn 0007-0920
188 1532-1827
189 schema:name British Journal of Cancer
190 schema:publisher Springer Nature
191 rdf:type schema:Periodical
192 sg:person.01116545420.18 schema:affiliation grid-institutes:None
193 schema:familyName Maddau
194 schema:givenName C
195 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01116545420.18
196 rdf:type schema:Person
197 sg:person.01174274056.26 schema:affiliation grid-institutes:None
198 schema:familyName Ciatto
199 schema:givenName S
200 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01174274056.26
201 rdf:type schema:Person
202 sg:person.01206540103.18 schema:affiliation grid-institutes:None
203 schema:familyName Ronco
204 schema:givenName G
205 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01206540103.18
206 rdf:type schema:Person
207 sg:person.01303355111.07 schema:affiliation grid-institutes:None
208 schema:familyName Noferini
209 schema:givenName D
210 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01303355111.07
211 rdf:type schema:Person
212 sg:person.0667445361.38 schema:affiliation grid-institutes:None
213 schema:familyName Confortini
214 schema:givenName M
215 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0667445361.38
216 rdf:type schema:Person
217 sg:person.0673306461.39 schema:affiliation grid-institutes:None
218 schema:familyName Carozzi
219 schema:givenName F
220 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0673306461.39
221 rdf:type schema:Person
222 sg:person.0743542266.47 schema:affiliation grid-institutes:None
223 schema:familyName Segnan
224 schema:givenName N
225 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0743542266.47
226 rdf:type schema:Person
227 sg:pub.10.1007/bf00051652 schema:sameAs https://app.dimensions.ai/details/publication/pub.1032711152
228 https://doi.org/10.1007/bf00051652
229 rdf:type schema:CreativeWork
230 sg:pub.10.1038/bjc.1989.236 schema:sameAs https://app.dimensions.ai/details/publication/pub.1022777795
231 https://doi.org/10.1038/bjc.1989.236
232 rdf:type schema:CreativeWork
233 sg:pub.10.1038/bjc.1991.350 schema:sameAs https://app.dimensions.ai/details/publication/pub.1042218657
234 https://doi.org/10.1038/bjc.1991.350
235 rdf:type schema:CreativeWork
236 sg:pub.10.1038/bjc.1995.347 schema:sameAs https://app.dimensions.ai/details/publication/pub.1010276001
237 https://doi.org/10.1038/bjc.1995.347
238 rdf:type schema:CreativeWork
239 sg:pub.10.1038/bjc.1997.440 schema:sameAs https://app.dimensions.ai/details/publication/pub.1010481383
240 https://doi.org/10.1038/bjc.1997.440
241 rdf:type schema:CreativeWork
242 sg:pub.10.1038/sj.bjc.6690523 schema:sameAs https://app.dimensions.ai/details/publication/pub.1041726872
243 https://doi.org/10.1038/sj.bjc.6690523
244 rdf:type schema:CreativeWork
245 sg:pub.10.1038/sj.bjc.6690730 schema:sameAs https://app.dimensions.ai/details/publication/pub.1011080887
246 https://doi.org/10.1038/sj.bjc.6690730
247 rdf:type schema:CreativeWork
248 grid-institutes:None schema:alternateName Cancer Epidemiology Unit, ASL TO1, Centre for Cancer Epidemiology and Prevention (CPO), Torino, Italy
249 Cytology Unit, Centre for Cancer Study and Prevention (CSPO), Firenze, Italy
250 Department of Diagnostic Medical Imaging, Centre for Cancer Study and Prevention (CSPO), Florence, Italy
251 schema:name Cancer Epidemiology Unit, ASL TO1, Centre for Cancer Epidemiology and Prevention (CPO), Torino, Italy
252 Cytology Unit, Centre for Cancer Study and Prevention (CSPO), Firenze, Italy
253 Department of Diagnostic Medical Imaging, Centre for Cancer Study and Prevention (CSPO), Florence, Italy
254 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...